Boston Scientific Corpora...

NYSE: BSX · Real-Time Price · USD
104.16
1.66 (1.62%)
At close: Aug 14, 2025, 3:59 PM
104.43
0.26%
Pre-market: Aug 15, 2025, 08:59 AM EDT

Boston Scientific Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
1.85B 1.59B 698M 1.04B
Depreciation & Amortization
1.27B 1.2B 1.14B 1.09B
Stock-Based Compensation
266M 233M 220M 194M
Other Working Capital
-126M 10M -209M -134M
Other Non-Cash Items
516M 253M 540M 18M
Deferred Income Tax
n/a -1M -63M -124M
Change in Working Capital
-462M -770M -1B -351M
Operating Cash Flow
3.44B 2.5B 1.53B 1.87B
Capital Expenditures
-790M -800M -612M -554M
Cash Acquisitions
-4.64B -1.81B -1.54B -1.43B
Purchase of Investments
n/a n/a -24M 96M
Sales Maturities Of Investments
n/a n/a 56M 294M
Other Investing Acitivies
-257M -52M 106M -1M
Investing Cash Flow
-5.69B -2.57B -2.01B -1.6B
Debt Repayment
1.83B -4M -165M n/a
Common Stock Repurchased
n/a n/a 136M n/a
Dividend Paid
n/a -28M -55M -55M
Other Financial Acitivies
-13M -145M -464M -150M
Financial Cash Flow
1.81B 5M -548M -95M
Net Cash Flow
-449M -82M -1.04B 171M
Free Cash Flow
2.65B 1.7B 914M 1.32B